Novel enzymes and metabolites involved in skatole metabolism
AssigneeUniversity of Guelph
InventorsE. Squires, Gonzalo Diaz
Life of this patent
Estimating the term…
Loading patent…
AssigneeUniversity of Guelph
InventorsE. Squires, Gonzalo Diaz
Estimating the term…
Novel metabolites and enzymes involved in skatole metabolism are disclosed. The novel metabolites are 3-OH-3-methylindolenine (HMI); 3-methyloxindole (3MOI); indole-3-carbinol (I-3C); and 2-aminoacetophenone (2-AM). Measuring levels of these metabolites in a pig may be useful in identifying the pig's ability to metabolize skatole and its susceptibility to boar taint. The novel enzymes involved in skatole metabolism are aldehyde oxidase and CYP2A6. Enhancing the activity of these enzymes may be useful in enhancing skatole metabolism and reducing boar taint. The identification of the enzyme also allows the development of screening assays for substances that interact with these enzymes and skatole metabolism. Pigs having high levels of these enzymes may be selected and bred to produce pigs that have a lower incidence of boar taint.
A method of assessing a pig's ability to metabolize 3-methyl indole comprising testing a sample from the pig for (a) one or more metabolites selected from the group consisting of 3-OH-3-methylindolenine (HMI);
A method for enhancing the metabolism of 3-methylindole in a pig comprising enhancing the activity of aldehyde oxidase in a pig.
A method for enhancing the metabolism of 3-methylindole comprising enhancing the activity of CYP2A6 in a pig.
A method for screening for a substance that enhances skatole metabolism in a pig by enhancing aldehyde oxidase activity comprising the steps of:
A method for screening for a substance that enhances skatole metabolism in a pig by enhancing CYP2A6 activity comprising the steps of:
A method for screening for a substance that enhances skatole metabolism by enhancing transcription and/or translation of the gene encoding aldehyde oxidase comprising the steps of:
A method for screening for a substance that enhances skatole metabolism by enhancing transcription and/or translation of the gene encoding CYP2A6 comprising the steps of:
A pharmaceutical composition for use in reducing boar taint comprising an effective amount of a substance which is selected from the group consisting of:
A method for producing pigs which have a lower incidence of boar taint comprising selecting pigs that express high levels of aldehyde oxidase and/or CYP2A6;
Dependencies are inferred from the claim text.